Sermorelin Acetate

Sermorelin is a copy of the front end of your natural growth-hormone-releasing hormone. It signals the pituitary to make its own growth hormone.

It's studied in performance and longevity research — testing whether the pituitary can still produce growth hormone on command.

It was historically FDA-approved (as Geref) for diagnosing childhood growth-hormone deficiency. That diagnostic use is established.

Distinguishes established clinical findings from early human trials, animal experiments, or laboratory cell culture findings. No human dosing, injection instructions, or treatment recommendations are provided.

Sermorelin was formerly FDA-approved for pediatric diagnostic use. BBOHC material is a research-grade reagent.

BBOHC LABS research reagents are non-clinical materials. An FDA approval for a finished medicine containing the same active ingredient does not imply that BBOHC's investigational research vial is FDA-approved.

Temporary facial flushing or injection-site warmth in diagnostic protocols.

• Prakash A et al. Sermorelin: review of its use in pediatric GH deficiency. BioDrugs. 1999.

Specific citations are provided for literature context. Product purity & lot verification documentation available on request.